Here, we find that Myo1b promoting young EC senescence, endothelial dysfunction, and inflammation is accompanied by the impairment of the autophagosome-lysosome fusion, which is reversed by the rapamycin that promotes autophagosome-lysosome fusion. This evidence concerns the gene MYO1B and endothelial dysfunction.